Elaine Johnstone
Departmental Lecturer
As a departmental lecturer and Co-Director of the MSc in Experimental and Translational Therapeutics (ETT), my overarching interest is in experimental medicine and patient variability in response. My current responsibilities on the MSc involve curriculum development and pedagogy, academic progress, dissertation development and supervision as well as pastoral support at a graduate and undergraduate level. I am keen to develop my research in education and am interested in outreach and the attainment gap.
I have a BSc in Medicinal Chemistry, an MSc in Molecular Pathology and Toxicology and a PhD in Molecular Pharmacology, which I competed at the Cancer Research Unit, University of Newcastle upon Tyne. After a fellowship studying differential drug response in sarcoma at the University of Bordeaux, I started working at the University of Oxford.
My research at Oxford initially focussed on cancer prevention, studying biological factors influencing effectiveness of smoking cessation therapies (eg NRT). This approach then shifted into cancer patients, identifying genomic factors that influence efficacy and side effects post-treatment. Although I have focussed mainly on biomarkers of treatment outcome, I also have an interest in healthy aging, cancer and exercise, and identifying high risk individuals using biomarkers.
I have a keen interest in education and lots of experience teaching and supporting students to achieve their potential. I recently gained a PGCert in Higher Teaching and Learning with distinction and also a Fellow of the HEA.
Recent publications
n Insight into Cancer Cells and Disease Progression Through the Lens of Mathematical Modeling.
Journal article
Michalakis P. et al, (2025), Curr Issues Mol Biol, 47
Synthesis, biological evaluation and mechanism study based on network pharmacology of amino acids esters of 20(S)-protopanaxadiol as novel anticancer agents.
Journal article
Xie H. et al, (2025), Fitoterapia, 180
Biophysical interactions between components of the tumor microenvironment promote metastasis.
Journal article
Vasilaki D. et al, (2021), Biophys Rev, 13, 339 - 357
The clinical landscape for AAV gene therapies.
Journal article
Kuzmin DA. et al, (2021), Nat Rev Drug Discov, 20, 173 - 174
Evaluation of the Response of HOS and Saos-2 Osteosarcoma Cell Lines When Exposed to Different Sizes and Concentrations of Silver Nanoparticles.
Journal article
Michalakis K. et al, (2021), Biomed Res Int, 2021